Medcomtech Balance Sheet Health

Financial Health criteria checks 2/6

Medcomtech has a total shareholder equity of €256.8K and total debt of €18.2M, which brings its debt-to-equity ratio to 7076.7%. Its total assets and total liabilities are €30.1M and €29.8M respectively. Medcomtech's EBIT is €1.0M making its interest coverage ratio 0.8. It has cash and short-term investments of €2.0M.

Key information

7,076.7%

Debt to equity ratio

€18.17m

Debt

Interest coverage ratio0.8x
Cash€1.99m
Equity€256.76k
Total liabilities€29.82m
Total assets€30.08m

Recent financial health updates

Here's Why Medcomtech (BME:MED) Can Afford Some Debt

May 17
Here's Why Medcomtech (BME:MED) Can Afford Some Debt

Recent updates

Returns Are Gaining Momentum At Medcomtech (BME:MED)

Oct 18
Returns Are Gaining Momentum At Medcomtech (BME:MED)

Many Still Looking Away From Medcomtech, S.A. (BME:MED)

Aug 26
Many Still Looking Away From Medcomtech, S.A. (BME:MED)

Returns At Medcomtech (BME:MED) Are On The Way Up

Mar 21
Returns At Medcomtech (BME:MED) Are On The Way Up

Medcomtech (BME:MED) Is Experiencing Growth In Returns On Capital

Dec 06
Medcomtech (BME:MED) Is Experiencing Growth In Returns On Capital

Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To Persist

Aug 16
Investors Will Want Medcomtech's (BME:MED) Growth In ROCE To Persist

Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On Capital

Apr 09
Medcomtech (BME:MED) Is Looking To Continue Growing Its Returns On Capital

Here's Why Medcomtech (BME:MED) Can Afford Some Debt

May 17
Here's Why Medcomtech (BME:MED) Can Afford Some Debt

Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Nov 30
Should Weakness in Medcomtech, S.A.'s (BME:MED) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Financial Position Analysis

Short Term Liabilities: MED's short term assets (€22.1M) exceed its short term liabilities (€13.8M).

Long Term Liabilities: MED's short term assets (€22.1M) exceed its long term liabilities (€16.0M).


Debt to Equity History and Analysis

Debt Level: MED's net debt to equity ratio (6300.1%) is considered high.

Reducing Debt: MED's debt to equity ratio has increased from 928.9% to 7076.7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if MED has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if MED has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies